• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给予人抗IL-12/23 p40单克隆抗体ABT-874后食蟹猴的产前和产后发育

Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.

作者信息

Enright Brian P, Tornesi Belen, Weinbauer Gerhard F, Blaich Guenter

机构信息

Abbott Laboratories, Abbott Park, Illinois 60064, USA.

出版信息

Birth Defects Res B Dev Reprod Toxicol. 2012 Dec;95(6):431-43. doi: 10.1002/bdrb.21034. Epub 2012 Dec 4.

DOI:10.1002/bdrb.21034
PMID:23212752
Abstract

BACKGROUND

ABT-874 is an anti-IL-12/23 monoclonal antibody that binds to the p40 subunit of human IL-12 and IL-23. As part of its preclinical safety assessment, studies were conducted to assess its potential effects on pre- and postnatal development in cynomolgus monkeys.

METHODS

In the embryo-fetal development studies, ABT-874 was administered once weekly subcutaneously to adult female cynomolgus monkeys at doses of 0, 5, 25, or 100 mg/kg during gestation days (GD) 20 to 48. Fetuses were examined for external, visceral, and skeletal development on GD 100 or 150. In the pre- and postnatal study, ABT-874 was administered once weekly subcutaneously to adult female cynomolgus monkeys at doses of 10, 50, or 200 mg/kg from GD 20 through postpartum day 182. Infants were examined from birth up to 9 months of age for morphological and functional development. Potential effects on the infant immune system were evaluated by immunophenotyping of peripheral blood lymphocytes and by T-dependent antibody response to KLH.

RESULTS

There was no ABT-874-related maternal toxicity or adverse effects on fetuses or infants. ABT-874 was present in maternal and fetal serum at GD 100 and 150, and in infant serum through day 63 postbirth. ABT-874 was also present at low levels in breast milk through postpartum day 175.

CONCLUSIONS

Exposure of cynomolgus monkey fetuses and infants to ABT-874 had no adverse effects on embryo-fetal or postnatal development.

摘要

背景

ABT - 874是一种抗白细胞介素12/23单克隆抗体,可与人白细胞介素12和白细胞介素23的p40亚基结合。作为其临床前安全性评估的一部分,开展了多项研究以评估其对食蟹猴产前和产后发育的潜在影响。

方法

在胚胎 - 胎儿发育研究中,于妊娠第20至48天,每周一次皮下给予成年雌性食蟹猴0、5、25或100 mg/kg剂量的ABT - 874。在妊娠第100天或150天检查胎儿的外部、内脏和骨骼发育情况。在产前和产后研究中,从妊娠第20天至产后第182天,每周一次皮下给予成年雌性食蟹猴10、50或200 mg/kg剂量的ABT - 874。对出生至9个月大的婴儿进行形态和功能发育检查。通过外周血淋巴细胞免疫表型分析以及对钥孔戚血蓝蛋白的T细胞依赖性抗体反应评估对婴儿免疫系统的潜在影响。

结果

未发现与ABT - 874相关的母体毒性,也未对胎儿或婴儿产生不良影响。在妊娠第100天和150天,母体和胎儿血清中存在ABT - 874,在出生后第63天婴儿血清中也存在。直至产后第175天,母乳中也存在低水平的ABT - 874。

结论

食蟹猴胎儿和婴儿接触ABT - 874对胚胎 - 胎儿或产后发育没有不良影响。

相似文献

1
Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.给予人抗IL-12/23 p40单克隆抗体ABT-874后食蟹猴的产前和产后发育
Birth Defects Res B Dev Reprod Toxicol. 2012 Dec;95(6):431-43. doi: 10.1002/bdrb.21034. Epub 2012 Dec 4.
2
Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation.在孕期和哺乳期给予人源抗IL-12/23 p40单克隆抗体优特克单抗后食蟹猴的发育情况。
Birth Defects Res B Dev Reprod Toxicol. 2010 Oct;89(5):351-63. doi: 10.1002/bdrb.20250.
3
Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.利妥昔单抗在食蟹猴中的发育免疫毒性评估。
Toxicol Sci. 2011 Jan;119(1):116-25. doi: 10.1093/toxsci/kfq316. Epub 2010 Oct 11.
4
Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.给予人源抗IL-12/23 p40单克隆抗体ABT-874后食蟹猴的雄性和雌性生育力评估
Birth Defects Res B Dev Reprod Toxicol. 2012 Dec;95(6):421-30. doi: 10.1002/bdrb.21031. Epub 2012 Dec 4.
5
Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.SA237,一种人源化抗白细胞介素-6 受体单克隆抗体,对食蟹猴产前和产后发育的影响。
Birth Defects Res. 2017 Jul 3;109(11):843-856. doi: 10.1002/bdr2.1036. Epub 2017 May 15.
6
An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.一项使用他巴鲁单抗(一种人IgG4单克隆抗体)对食蟹猴进行的增强型产前和产后发育研究。
Birth Defects Res B Dev Reprod Toxicol. 2015 Jun;104(3):100-16. doi: 10.1002/bdrb.21146. Epub 2015 Jul 20.
7
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.抗胰岛素样生长因子-1受体(IGF-1R)单克隆抗体菲妥珠单抗对食蟹猴的胚胎-胎儿发育毒性
Birth Defects Res B Dev Reprod Toxicol. 2010 Aug;89(4):326-38. doi: 10.1002/bdrb.20248.
8
Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor.食蟹猴在产前暴露于α4整合素抑制剂那他珠单抗后的产后发育。
Birth Defects Res B Dev Reprod Toxicol. 2009 Apr;86(2):144-56. doi: 10.1002/bdrb.20193.
9
Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option.单克隆抗体的发育毒性试验:一种改进的产前和产后研究设计方案。
Reprod Toxicol. 2009 Sep;28(2):220-5. doi: 10.1016/j.reprotox.2009.04.002. Epub 2009 Apr 18.
10
Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys.评估白细胞介素-17A单克隆抗体司库奇尤单抗对食蟹猴生殖和发育(包括免疫系统功能)的潜在影响。
Reprod Toxicol. 2015 Dec;58:160-73. doi: 10.1016/j.reprotox.2015.10.008. Epub 2015 Oct 19.

引用本文的文献

1
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.接受优特克单抗治疗的克罗恩病患者发生宫内胎儿死亡和流产:病例报告及文献综述
BMC Gastroenterol. 2017 Jun 19;17(1):80. doi: 10.1186/s12876-017-0633-6.
2
Ustekinumab for the treatment of Crohn's disease: can it find its niche?优特克单抗治疗克罗恩病:它能找到自己的用武之地吗?
Therap Adv Gastroenterol. 2016 Jan;9(1):26-36. doi: 10.1177/1756283X15618130.